These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37742362)

  • 61. Simultaneous determination of triamcinolone acetonide and oxymetazoline hydrochloride in nasal spray formulations by HPLC.
    Sudsakorn S; Kaplan L; Williams DA
    J Pharm Biomed Anal; 2006 Mar; 40(5):1273-80. PubMed ID: 16297589
    [TBL] [Abstract][Full Text] [Related]  

  • 62. PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide.
    Al-Zuhairy SAS; Teaima MH; Shoman NA; Elasaly M; El-Nabarawi MA; El-Sawy HS
    Drug Deliv; 2023 Dec; 30(1):2189112. PubMed ID: 36916128
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cationic Nano-Lipidic Carrier Mediated Ocular Delivery of Triamcinolone Acetonide: A Preclinical Investigation in the Management of Uveitis.
    Nirbhavane P; Moksha L; Sharma G; Velpandian T; Singh B; Katare OP
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109586
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Application of electrospraying as a one-step method for the fabrication of triamcinolone acetonide-PLGA nanofibers and nanobeads.
    Jahangiri A; Davaran S; Fayyazi B; Tanhaei A; Payab S; Adibkia K
    Colloids Surf B Biointerfaces; 2014 Nov; 123():219-24. PubMed ID: 25260224
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T; Dhawan M; Garg S; Nair S; Mandal S
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter.
    Nishimura A; Kobayashi A; Segawa Y; Sakurai M; Shirao E; Shirao Y; Sugiyama K
    Retina; 2003 Dec; 23(6):777-9. PubMed ID: 14707826
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Design and evaluation of thermo-responsive nasal in situ gelling system dispersed with piribedil loaded lecithin-chitosan hybrid nanoparticles for improved brain availability.
    Uppuluri CT; Ravi PR; Dalvi AV
    Neuropharmacology; 2021 Dec; 201():108832. PubMed ID: 34627852
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
    Edelman JL; Lutz D; Castro MR
    Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis.
    Jeal W; Faulds D
    Drugs; 1997 Feb; 53(2):257-80. PubMed ID: 9028745
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determination of physicochemical properties and degradation kinetics of triamcinolone acetonide palmitate in vitro.
    Peng C; Liu C; Tang X
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1469-76. PubMed ID: 20524902
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of triamcinolone acetonide on adult human lung fibroblasts: decrease in proliferation, surface molecule expression and mediator release.
    Oddera S; Cagnoni F; Mangraviti S; Giron-Michel J; Popova O; Canonica GW
    Int Arch Allergy Immunol; 2002 Oct; 129(2):152-9. PubMed ID: 12403933
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
    Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN
    Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: an in vitro stability assessment.
    Veurink M; Stella C; Tabatabay C; Pournaras CJ; Gurny R
    Eur J Pharm Biopharm; 2011 Jun; 78(2):271-7. PubMed ID: 21172437
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review.
    José-Vieira R; Ferreira A; Menéres P; Sousa-Pinto B; Figueira L
    Surv Ophthalmol; 2022; 67(4):991-1013. PubMed ID: 34896190
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.
    Li W; He B; Dai W; Zhang Q; Liu Y
    Int Ophthalmol; 2014 Jun; 34(3):465-76. PubMed ID: 23868505
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear.
    Engleder E; Honeder C; Klobasa J; Wirth M; Arnoldner C; Gabor F
    Int J Pharm; 2014 Aug; 471(1-2):297-302. PubMed ID: 24907595
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of a novel triamcinolone acetonide-loaded spray solution for the treatment of stomatitis.
    Kim DW; Kim YI; Ud Din F; Cho KH; Kim JO; Choi HG
    Pharmazie; 2014 Jul; 69(7):512-7. PubMed ID: 25073396
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation.
    Xing Y; Zhu L; Zhang K; Li T; Huang S
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):308-316. PubMed ID: 33739906
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A new solution-based intranasal triamcinolone acetonide formulation in patients with perennial allergic rhinitis: how does the pharmacokinetic/pharmacodynamic profile for cortisol suppression compare with an aqueous suspension-based formulation?
    Hochhaus G; González MA; Dockhorn RJ; Shilstone J; Karafilidis J
    J Clin Pharmacol; 2002 Jun; 42(6):662-9. PubMed ID: 12043955
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A combined micelle and poly(serinol hexamethylene urea)-co-poly(N-isopropylacrylamide) reverse thermal gel as an injectable ocular drug delivery system.
    Famili A; Kahook MY; Park D
    Macromol Biosci; 2014 Dec; 14(12):1719-29. PubMed ID: 25187427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.